Page last updated: 2024-09-03

n,n-dimethylarginine and cyproterone acetate

n,n-dimethylarginine has been researched along with cyproterone acetate in 5 studies

Compound Research Comparison

Studies (n,n-dimethylarginine)	Trials (n,n-dimethylarginine)	Recent Studies (post-2010) (n,n-dimethylarginine)	Studies (cyproterone acetate)	Trials (cyproterone acetate)	Recent Studies (post-2010) (cyproterone acetate)
2,216	228	1,221	1,845	339	261

Protein Interaction Comparison

Protein	Taxonomy	cyproterone acetate (IC50)
Glucocorticoid receptor	Homo sapiens (human)	0.225
Glycine receptor subunit alpha-1	Rattus norvegicus (Norway rat)	0.225
Androgen receptor	Homo sapiens (human)	0.1408
Androgen receptor	Rattus norvegicus (Norway rat)	0.339
Glycine receptor subunit beta	Rattus norvegicus (Norway rat)	0.225
Glycine receptor subunit alpha-2	Rattus norvegicus (Norway rat)	0.225
Glycine receptor subunit alpha-3	Rattus norvegicus (Norway rat)	0.225
Adenosine receptor A1	Rattus norvegicus (Norway rat)	0.045
Mu-type opioid receptor	Homo sapiens (human)	2.183

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V	1
Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z	1
Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S	1
Bunck, MC; Diamant, M; Giltay, EJ; Gooren, LJ; Teerlink, T	1
Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B	1

Trials

2 trial(s) available for n,n-dimethylarginine and cyproterone acetate

Article	Year
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome. Atherosclerosis, 2008, Volume: 196, Issue:2 Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome	2008
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. Fertility and sterility, 2010, Volume: 93, Issue:1 Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor	2010

Article

Year

The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.

Atherosclerosis, 2008, Volume: 196, Issue:2

Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome

2008

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.

Fertility and sterility, 2010, Volume: 93, Issue:1

Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor

2010

Other Studies

3 other study(ies) available for n,n-dimethylarginine and cyproterone acetate

Article	Year
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS). Atherosclerosis, 2008, Volume: 200, Issue:2 Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors	2008
Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals. Atherosclerosis, 2009, Volume: 206, Issue:1 Topics: Adult; Amino Acids; Androgen Antagonists; Arginine; Cyproterone Acetate; Estradiol; Estrogens; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Male; Testosterone; Transsexualism	2009
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome. Archives of gynecology and obstetrics, 2014, Volume: 289, Issue:1 Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult	2014